Yc. Jang et al., CHANGES IN MATRIX COMPOSITION DURING THE GROWTH AND REGRESSION OF HUMAN HEMANGIOMAS, The Journal of surgical research (Print), 80(1), 1998, pp. 9-15
Background. Hemangiomas offer an uncommon opportunity to study rapid v
essel growth and spontaneous regression of a vascular human tumor. In
contrast, venous malformations are another type of vascular tumor that
grows slowly without spontaneous involution. Extracellular matrix (EC
M) molecules modulate the responsiveness of endothelial cells to mitog
enic stimuli such as basic fibroblast growth factor (bFGF), a well-rec
ognized stimulant of angiogenesis. In this study we hypothesized that
in hemangiomas, sites of angiogenesis may have a different ECM composi
tion than sites of vascular regression. Materials and methods. Using i
mmunohistochemistry, we analyzed proliferating hemangiomas, regressing
hemangiomas, venous malformations, and normal skin for the basement m
embrane ECM molecules collagen IV and laminin and plasma-borne ECM mol
ecules fibronectin and vitronectin. We used metabolic labeling to dete
rmine whether primary human dermal microvascular endothelial cells reg
ulated FGFR-1 or FGFR-2 when grown on these different matrices. Result
s. We found that proliferating hemangiomas showed extensive deposition
of vitronectin in the subendothelial space. In contrast, regressing h
emangiomas or venous malformations did not show vitronectin deposition
. Venous malformations, which are composed of ectatic lakes of venous
channels, also lacked laminin in their basement membranes. We also fou
nd that cultured microvascular endothelial cells grown on vitronectin
increased synthesis of FGFR-1 and FGFR-2 protein. Conclusions. Changes
in the ECM environment occur in conjunction with the angiogenic state
of a vascular human tumor. Furthermore, changes in the ECM environmen
t alone can directly regulate synthesis of angiogenic growth factor re
ceptors. (C) 1998 Academic Press.